The patent for ACULAR LS (ketorolac tromethamine), held by Abbvie, is set to expire on November 28, 2024.
Zero-Day Attack Exploits Corrupted Files to Evade Advanced Security Tools
Cybersecurity experts at ANY.RUN have discovered a zero-day attack campaign that uses corrupted files to evade detection by antivirus software and email spam filters. The